 Patients over 10 years of age with sight-threatening retinal vasculitis may be eligible for this study. page 6 of the protocol, under 4 Study Design and Methods, says the age range is 2 years old and above; page 10, under 5 Participant Inclusion and Exclusion Criteria, says initial enrollment will include all patients over the age of 10 years. 